chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Brain natriuretic peptide, C-reactive protein, Chills, Condition aggravated, Electrocardiogram
Clinical narrative: Status epilepticus; epilepsy; headache; fatigue; myalgias; chills; no tactile fever; epilepsy; This is a spontaneous report received from a contactable consumer (patient's parent). A 12-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration in left arm on 14Jun2021 at 09:00 PM as 2ND DOSE, SINGLE for covid-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration (at the age of 12 year) in left arm on 22May2021 at 02:00 PM for covid-19 immunisation. Medical history included epilepsy (well-controlled on medication) from an unknown date and unknown if ongoing. Concomitant medications included oxcarbazepine (TRILEPTAL); lamotrigine (LAMICTAL), multivitamin, vitamin D supplement. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19. On 15Jun2021 at 04:00 AM, patient experienced status epilepticus in adolescent with generally well-controlled epilepsy (last seizure in Sep2020) starting 31 hours after receiving second dose of Pfizer Covid vaccine. Prior to seizure onset, had symptoms of headache, fatigue, myalgias, chills, no tactile fever for approximately 16 hours before seizures began. Febrile to 101 at time of arrival to hospital (approximately1 hour after first seizure). The patient underwent lab tests and procedures which included body temperature: 101 on 15Jun2021, sars-cov-2 test: negative on 15Jun2021. The events resulted in: Emergency room/department or urgent care, hospitalization. The patient received treatment due to the events with emergent administration of benzodiazepines and fosphenytoin. The outcome of events was recovering.  Information regarding the Lot/Batch number has been requested.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electroencephalogram, Fatigue, Full blood count, Headache, Metabolic function test
Clinical narrative: Status epilepticus; epilepsy; headache; fatigue; myalgias; chills; no tactile fever; epilepsy; This is a spontaneous report received from a contactable consumer (patient's parent). A 12-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration in left arm on 14Jun2021 at 09:00 PM as 2ND DOSE, SINGLE for covid-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration (at the age of 12 year) in left arm on 22May2021 at 02:00 PM for covid-19 immunisation. Medical history included epilepsy (well-controlled on medication) from an unknown date and unknown if ongoing. Concomitant medications included oxcarbazepine (TRILEPTAL); lamotrigine (LAMICTAL), multivitamin, vitamin D supplement. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19. On 15Jun2021 at 04:00 AM, patient experienced status epilepticus in adolescent with generally well-controlled epilepsy (last seizure in Sep2020) starting 31 hours after receiving second dose of Pfizer Covid vaccine. Prior to seizure onset, had symptoms of headache, fatigue, myalgias, chills, no tactile fever for approximately 16 hours before seizures began. Febrile to 101 at time of arrival to hospital (approximately1 hour after first seizure). The patient underwent lab tests and procedures which included body temperature: 101 on 15Jun2021, sars-cov-2 test: negative on 15Jun2021. The events resulted in: Emergency room/department or urgent care, hospitalization. The patient received treatment due to the events with emergent administration of benzodiazepines and fosphenytoin. The outcome of events was recovering.  Information regarding the Lot/Batch number has been requested.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myalgia, Pyrexia, SARS-CoV-2 test negative, Status epilepticus, Troponin
Clinical narrative: Status epilepticus; epilepsy; headache; fatigue; myalgias; chills; no tactile fever; epilepsy; This is a spontaneous report received from a contactable consumer (patient's parent). A 12-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration in left arm on 14Jun2021 at 09:00 PM as 2ND DOSE, SINGLE for covid-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration (at the age of 12 year) in left arm on 22May2021 at 02:00 PM for covid-19 immunisation. Medical history included epilepsy (well-controlled on medication) from an unknown date and unknown if ongoing. Concomitant medications included oxcarbazepine (TRILEPTAL); lamotrigine (LAMICTAL), multivitamin, vitamin D supplement. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19. On 15Jun2021 at 04:00 AM, patient experienced status epilepticus in adolescent with generally well-controlled epilepsy (last seizure in Sep2020) starting 31 hours after receiving second dose of Pfizer Covid vaccine. Prior to seizure onset, had symptoms of headache, fatigue, myalgias, chills, no tactile fever for approximately 16 hours before seizures began. Febrile to 101 at time of arrival to hospital (approximately1 hour after first seizure). The patient underwent lab tests and procedures which included body temperature: 101 on 15Jun2021, sars-cov-2 test: negative on 15Jun2021. The events resulted in: Emergency room/department or urgent care, hospitalization. The patient received treatment due to the events with emergent administration of benzodiazepines and fosphenytoin. The outcome of events was recovering.  Information regarding the Lot/Batch number has been requested.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anion gap increased, Blood bicarbonate decreased, Blood pH, C-reactive protein increased, Condition aggravated
Clinical narrative: Status epilepticus; epilepsy; headache; fatigue; myalgias; chills; no tactile fever; epilepsy; This is a spontaneous report received from a contactable consumer (patient's parent). A 12-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration in left arm on 14Jun2021 at 09:00 PM as 2ND DOSE, SINGLE for covid-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration (at the age of 12 year) in left arm on 22May2021 at 02:00 PM for covid-19 immunisation. Medical history included epilepsy (well-controlled on medication) from an unknown date and unknown if ongoing. Concomitant medications included oxcarbazepine (TRILEPTAL); lamotrigine (LAMICTAL), multivitamin, vitamin D supplement. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19. On 15Jun2021 at 04:00 AM, patient experienced status epilepticus in adolescent with generally well-controlled epilepsy (last seizure in Sep2020) starting 31 hours after receiving second dose of Pfizer Covid vaccine. Prior to seizure onset, had symptoms of headache, fatigue, myalgias, chills, no tactile fever for approximately 16 hours before seizures began. Febrile to 101 at time of arrival to hospital (approximately1 hour after first seizure). The patient underwent lab tests and procedures which included body temperature: 101 on 15Jun2021, sars-cov-2 test: negative on 15Jun2021. The events resulted in: Emergency room/department or urgent care, hospitalization. The patient received treatment due to the events with emergent administration of benzodiazepines and fosphenytoin. The outcome of events was recovering.  Information regarding the Lot/Batch number has been requested.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyskinesia, Electrocardiogram normal, Electroencephalogram normal, Eye movement disorder, Fatigue
Clinical narrative: Status epilepticus; epilepsy; headache; fatigue; myalgias; chills; no tactile fever; epilepsy; This is a spontaneous report received from a contactable consumer (patient's parent). A 12-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration in left arm on 14Jun2021 at 09:00 PM as 2ND DOSE, SINGLE for covid-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration (at the age of 12 year) in left arm on 22May2021 at 02:00 PM for covid-19 immunisation. Medical history included epilepsy (well-controlled on medication) from an unknown date and unknown if ongoing. Concomitant medications included oxcarbazepine (TRILEPTAL); lamotrigine (LAMICTAL), multivitamin, vitamin D supplement. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19. On 15Jun2021 at 04:00 AM, patient experienced status epilepticus in adolescent with generally well-controlled epilepsy (last seizure in Sep2020) starting 31 hours after receiving second dose of Pfizer Covid vaccine. Prior to seizure onset, had symptoms of headache, fatigue, myalgias, chills, no tactile fever for approximately 16 hours before seizures began. Febrile to 101 at time of arrival to hospital (approximately1 hour after first seizure). The patient underwent lab tests and procedures which included body temperature: 101 on 15Jun2021, sars-cov-2 test: negative on 15Jun2021. The events resulted in: Emergency room/department or urgent care, hospitalization. The patient received treatment due to the events with emergent administration of benzodiazepines and fosphenytoin. The outcome of events was recovering.  Information regarding the Lot/Batch number has been requested.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Laboratory test, Laboratory test normal, Pyrexia, Seizure, Status epilepticus
Clinical narrative: Status epilepticus; epilepsy; headache; fatigue; myalgias; chills; no tactile fever; epilepsy; This is a spontaneous report received from a contactable consumer (patient's parent). A 12-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration in left arm on 14Jun2021 at 09:00 PM as 2ND DOSE, SINGLE for covid-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration (at the age of 12 year) in left arm on 22May2021 at 02:00 PM for covid-19 immunisation. Medical history included epilepsy (well-controlled on medication) from an unknown date and unknown if ongoing. Concomitant medications included oxcarbazepine (TRILEPTAL); lamotrigine (LAMICTAL), multivitamin, vitamin D supplement. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19. On 15Jun2021 at 04:00 AM, patient experienced status epilepticus in adolescent with generally well-controlled epilepsy (last seizure in Sep2020) starting 31 hours after receiving second dose of Pfizer Covid vaccine. Prior to seizure onset, had symptoms of headache, fatigue, myalgias, chills, no tactile fever for approximately 16 hours before seizures began. Febrile to 101 at time of arrival to hospital (approximately1 hour after first seizure). The patient underwent lab tests and procedures which included body temperature: 101 on 15Jun2021, sars-cov-2 test: negative on 15Jun2021. The events resulted in: Emergency room/department or urgent care, hospitalization. The patient received treatment due to the events with emergent administration of benzodiazepines and fosphenytoin. The outcome of events was recovering.  Information regarding the Lot/Batch number has been requested.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tachycardia, White blood cell count normal
Clinical narrative: Status epilepticus; epilepsy; headache; fatigue; myalgias; chills; no tactile fever; epilepsy; This is a spontaneous report received from a contactable consumer (patient's parent). A 12-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration in left arm on 14Jun2021 at 09:00 PM as 2ND DOSE, SINGLE for covid-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration (at the age of 12 year) in left arm on 22May2021 at 02:00 PM for covid-19 immunisation. Medical history included epilepsy (well-controlled on medication) from an unknown date and unknown if ongoing. Concomitant medications included oxcarbazepine (TRILEPTAL); lamotrigine (LAMICTAL), multivitamin, vitamin D supplement. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19. On 15Jun2021 at 04:00 AM, patient experienced status epilepticus in adolescent with generally well-controlled epilepsy (last seizure in Sep2020) starting 31 hours after receiving second dose of Pfizer Covid vaccine. Prior to seizure onset, had symptoms of headache, fatigue, myalgias, chills, no tactile fever for approximately 16 hours before seizures began. Febrile to 101 at time of arrival to hospital (approximately1 hour after first seizure). The patient underwent lab tests and procedures which included body temperature: 101 on 15Jun2021, sars-cov-2 test: negative on 15Jun2021. The events resulted in: Emergency room/department or urgent care, hospitalization. The patient received treatment due to the events with emergent administration of benzodiazepines and fosphenytoin. The outcome of events was recovering.  Information regarding the Lot/Batch number has been requested.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Body temperature, Chills, Disease recurrence, Epilepsy, Fatigue
Clinical narrative: Status epilepticus; epilepsy; headache; fatigue; myalgias; chills; no tactile fever; epilepsy; This is a spontaneous report received from a contactable consumer (patient's parent). A 12-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration in left arm on 14Jun2021 at 09:00 PM as 2ND DOSE, SINGLE for covid-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration (at the age of 12 year) in left arm on 22May2021 at 02:00 PM for covid-19 immunisation. Medical history included epilepsy (well-controlled on medication) from an unknown date and unknown if ongoing. Concomitant medications included oxcarbazepine (TRILEPTAL); lamotrigine (LAMICTAL), multivitamin, vitamin D supplement. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19. On 15Jun2021 at 04:00 AM, patient experienced status epilepticus in adolescent with generally well-controlled epilepsy (last seizure in Sep2020) starting 31 hours after receiving second dose of Pfizer Covid vaccine. Prior to seizure onset, had symptoms of headache, fatigue, myalgias, chills, no tactile fever for approximately 16 hours before seizures began. Febrile to 101 at time of arrival to hospital (approximately1 hour after first seizure). The patient underwent lab tests and procedures which included body temperature: 101 on 15Jun2021, sars-cov-2 test: negative on 15Jun2021. The events resulted in: Emergency room/department or urgent care, hospitalization. The patient received treatment due to the events with emergent administration of benzodiazepines and fosphenytoin. The outcome of events was recovering.  Information regarding the Lot/Batch number has been requested.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Myalgia, Pyrexia, SARS-CoV-2 test, Status epilepticus
Clinical narrative: Status epilepticus; epilepsy; headache; fatigue; myalgias; chills; no tactile fever; epilepsy; This is a spontaneous report received from a contactable consumer (patient's parent). A 12-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration in left arm on 14Jun2021 at 09:00 PM as 2ND DOSE, SINGLE for covid-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration (at the age of 12 year) in left arm on 22May2021 at 02:00 PM for covid-19 immunisation. Medical history included epilepsy (well-controlled on medication) from an unknown date and unknown if ongoing. Concomitant medications included oxcarbazepine (TRILEPTAL); lamotrigine (LAMICTAL), multivitamin, vitamin D supplement. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19. On 15Jun2021 at 04:00 AM, patient experienced status epilepticus in adolescent with generally well-controlled epilepsy (last seizure in Sep2020) starting 31 hours after receiving second dose of Pfizer Covid vaccine. Prior to seizure onset, had symptoms of headache, fatigue, myalgias, chills, no tactile fever for approximately 16 hours before seizures began. Febrile to 101 at time of arrival to hospital (approximately1 hour after first seizure). The patient underwent lab tests and procedures which included body temperature: 101 on 15Jun2021, sars-cov-2 test: negative on 15Jun2021. The events resulted in: Emergency room/department or urgent care, hospitalization. The patient received treatment due to the events with emergent administration of benzodiazepines and fosphenytoin. The outcome of events was recovering.  Information regarding the Lot/Batch number has been requested.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal distension, Cervical polyp, Paraesthesia, Pelvic pain, Vaccination site pain
Clinical narrative: feminine blood spotting starting about 4 days pos 2nd injection. Early menstruation cycle start leading to continuous spotting between cycles. Periods are irregularly heavy and consist of tissue and clotting materials. Cramping leading to bed rest requiring medication and heat.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: feminine blood spotting starting about 4 days pos 2nd injection. Early menstruation cycle start leading to continuous spotting between cycles. Periods are irregularly heavy and consist of tissue and clotting materials. Cramping leading to bed rest requiring medication and heat.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Intermenstrual bleeding, Menstrual disorder, Polymenorrhoea
Clinical narrative: feminine blood spotting starting about 4 days pos 2nd injection. Early menstruation cycle start leading to continuous spotting between cycles. Periods are irregularly heavy and consist of tissue and clotting materials. Cramping leading to bed rest requiring medication and heat.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombosis
Clinical narrative: feminine blood spotting starting about 4 days pos 2nd injection. Early menstruation cycle start leading to continuous spotting between cycles. Periods are irregularly heavy and consist of tissue and clotting materials. Cramping leading to bed rest requiring medication and heat.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Cold sweat, Dizziness, Dyspnoea, Echocardiogram normal
Clinical narrative: Myocarditis
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram normal, Nausea, Palpitations, Pyrexia, Troponin I
Clinical narrative: Myocarditis
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Troponin I
Clinical narrative: Myocarditis
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood test, Chest pain, Computerised tomogram, Dyspnoea
Clinical narrative: Patient presented to ED 6/16 with chest pain.  Patient got her second Covid vaccination a week ago today.  That night she said she had some numbness on her face from mid lip and chin to the left side of her face.  When she went to bed that night she slept when she woke up that numbness was gone and has not had any since.  She is having body aches now she said the next day she had a lot of bilateral hip pain that seemed to improve some but now it is pain mainly in her back both upper and lower in her ribs.  She also has some anterior chest pain feels short of breath hurts to take a deep breath. No other complaints she says she is had some low-grade temperatures in the low 100 200.2 may be 100.5 periodically and some chills. Patient was in fair amount of discomfort very pleuritic breathing.  Given 50 mcg of fentanyl 4 mg Zofran IV.  She actually doing better.  Reviewing her records her platelets run about 240,000.  This is cut in half.  She did not have a significant headache and not concerned about an venous thrombosis in the brain however I am concerned about a pulmonary embolism. CT scan obtained and reviewed as below negative for PE or acute abnormality.  Repeat troponin negative, doubt ACS. Possible Covid reaction.  No other significant findings on ED work-up today.  Patient given IV Decadron and repeat dose of fentanyl. She is comfortable with plan discharge home with close outpatient follow-up. Presented again to ED 6/20 with 12 hours of progressive now constant severe low back pain radiating diffusely about the low back into both hips down the back of both legs. Told to F/U with PCP. F/U with PCP on 6/21 and 6/23. One possibility is new onset ITP or immune thrombocytopenia. Plan to Prednisone taper over 3 weeks, also H2 blocker prescribed. CBC twice weekly; follow up CMP with next draw . CTA abdomen rule out portal/mesenteric vein thrombosis or consumptive thrombocytopenia. Tramadol prn pain.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer, Headache, Hypoaesthesia, Muscle spasms, Neck pain
Clinical narrative: Patient presented to ED 6/16 with chest pain.  Patient got her second Covid vaccination a week ago today.  That night she said she had some numbness on her face from mid lip and chin to the left side of her face.  When she went to bed that night she slept when she woke up that numbness was gone and has not had any since.  She is having body aches now she said the next day she had a lot of bilateral hip pain that seemed to improve some but now it is pain mainly in her back both upper and lower in her ribs.  She also has some anterior chest pain feels short of breath hurts to take a deep breath. No other complaints she says she is had some low-grade temperatures in the low 100 200.2 may be 100.5 periodically and some chills. Patient was in fair amount of discomfort very pleuritic breathing.  Given 50 mcg of fentanyl 4 mg Zofran IV.  She actually doing better.  Reviewing her records her platelets run about 240,000.  This is cut in half.  She did not have a significant headache and not concerned about an venous thrombosis in the brain however I am concerned about a pulmonary embolism. CT scan obtained and reviewed as below negative for PE or acute abnormality.  Repeat troponin negative, doubt ACS. Possible Covid reaction.  No other significant findings on ED work-up today.  Patient given IV Decadron and repeat dose of fentanyl. She is comfortable with plan discharge home with close outpatient follow-up. Presented again to ED 6/20 with 12 hours of progressive now constant severe low back pain radiating diffusely about the low back into both hips down the back of both legs. Told to F/U with PCP. F/U with PCP on 6/21 and 6/23. One possibility is new onset ITP or immune thrombocytopenia. Plan to Prednisone taper over 3 weeks, also H2 blocker prescribed. CBC twice weekly; follow up CMP with next draw . CTA abdomen rule out portal/mesenteric vein thrombosis or consumptive thrombocytopenia. Tramadol prn pain.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Platelet count decreased, Pyrexia
Clinical narrative: Patient presented to ED 6/16 with chest pain.  Patient got her second Covid vaccination a week ago today.  That night she said she had some numbness on her face from mid lip and chin to the left side of her face.  When she went to bed that night she slept when she woke up that numbness was gone and has not had any since.  She is having body aches now she said the next day she had a lot of bilateral hip pain that seemed to improve some but now it is pain mainly in her back both upper and lower in her ribs.  She also has some anterior chest pain feels short of breath hurts to take a deep breath. No other complaints she says she is had some low-grade temperatures in the low 100 200.2 may be 100.5 periodically and some chills. Patient was in fair amount of discomfort very pleuritic breathing.  Given 50 mcg of fentanyl 4 mg Zofran IV.  She actually doing better.  Reviewing her records her platelets run about 240,000.  This is cut in half.  She did not have a significant headache and not concerned about an venous thrombosis in the brain however I am concerned about a pulmonary embolism. CT scan obtained and reviewed as below negative for PE or acute abnormality.  Repeat troponin negative, doubt ACS. Possible Covid reaction.  No other significant findings on ED work-up today.  Patient given IV Decadron and repeat dose of fentanyl. She is comfortable with plan discharge home with close outpatient follow-up. Presented again to ED 6/20 with 12 hours of progressive now constant severe low back pain radiating diffusely about the low back into both hips down the back of both legs. Told to F/U with PCP. F/U with PCP on 6/21 and 6/23. One possibility is new onset ITP or immune thrombocytopenia. Plan to Prednisone taper over 3 weeks, also H2 blocker prescribed. CBC twice weekly; follow up CMP with next draw . CTA abdomen rule out portal/mesenteric vein thrombosis or consumptive thrombocytopenia. Tramadol prn pain.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, Chest pain, Chills, Computerised tomogram normal
Clinical narrative: Patient presented to ED 6/16 with chest pain.  Patient got her second Covid vaccination a week ago today.  That night she said she had some numbness on her face from mid lip and chin to the left side of her face.  When she went to bed that night she slept when she woke up that numbness was gone and has not had any since.  She is having body aches now she said the next day she had a lot of bilateral hip pain that seemed to improve some but now it is pain mainly in her back both upper and lower in her ribs.  She also has some anterior chest pain feels short of breath hurts to take a deep breath. No other complaints she says she is had some low-grade temperatures in the low 100 200.2 may be 100.5 periodically and some chills. Patient was in fair amount of discomfort very pleuritic breathing.  Given 50 mcg of fentanyl 4 mg Zofran IV.  She actually doing better.  Reviewing her records her platelets run about 240,000.  This is cut in half.  She did not have a significant headache and not concerned about an venous thrombosis in the brain however I am concerned about a pulmonary embolism. CT scan obtained and reviewed as below negative for PE or acute abnormality.  Repeat troponin negative, doubt ACS. Possible Covid reaction.  No other significant findings on ED work-up today.  Patient given IV Decadron and repeat dose of fentanyl. She is comfortable with plan discharge home with close outpatient follow-up. Presented again to ED 6/20 with 12 hours of progressive now constant severe low back pain radiating diffusely about the low back into both hips down the back of both legs. Told to F/U with PCP. F/U with PCP on 6/21 and 6/23. One possibility is new onset ITP or immune thrombocytopenia. Plan to Prednisone taper over 3 weeks, also H2 blocker prescribed. CBC twice weekly; follow up CMP with next draw . CTA abdomen rule out portal/mesenteric vein thrombosis or consumptive thrombocytopenia. Tramadol prn pain.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Discomfort, Dyspnoea, Hypoaesthesia, Hypoaesthesia oral, Musculoskeletal chest pain
Clinical narrative: Patient presented to ED 6/16 with chest pain.  Patient got her second Covid vaccination a week ago today.  That night she said she had some numbness on her face from mid lip and chin to the left side of her face.  When she went to bed that night she slept when she woke up that numbness was gone and has not had any since.  She is having body aches now she said the next day she had a lot of bilateral hip pain that seemed to improve some but now it is pain mainly in her back both upper and lower in her ribs.  She also has some anterior chest pain feels short of breath hurts to take a deep breath. No other complaints she says she is had some low-grade temperatures in the low 100 200.2 may be 100.5 periodically and some chills. Patient was in fair amount of discomfort very pleuritic breathing.  Given 50 mcg of fentanyl 4 mg Zofran IV.  She actually doing better.  Reviewing her records her platelets run about 240,000.  This is cut in half.  She did not have a significant headache and not concerned about an venous thrombosis in the brain however I am concerned about a pulmonary embolism. CT scan obtained and reviewed as below negative for PE or acute abnormality.  Repeat troponin negative, doubt ACS. Possible Covid reaction.  No other significant findings on ED work-up today.  Patient given IV Decadron and repeat dose of fentanyl. She is comfortable with plan discharge home with close outpatient follow-up. Presented again to ED 6/20 with 12 hours of progressive now constant severe low back pain radiating diffusely about the low back into both hips down the back of both legs. Told to F/U with PCP. F/U with PCP on 6/21 and 6/23. One possibility is new onset ITP or immune thrombocytopenia. Plan to Prednisone taper over 3 weeks, also H2 blocker prescribed. CBC twice weekly; follow up CMP with next draw . CTA abdomen rule out portal/mesenteric vein thrombosis or consumptive thrombocytopenia. Tramadol prn pain.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain in extremity, Platelet count normal, Pleurisy, Pyrexia
Clinical narrative: Patient presented to ED 6/16 with chest pain.  Patient got her second Covid vaccination a week ago today.  That night she said she had some numbness on her face from mid lip and chin to the left side of her face.  When she went to bed that night she slept when she woke up that numbness was gone and has not had any since.  She is having body aches now she said the next day she had a lot of bilateral hip pain that seemed to improve some but now it is pain mainly in her back both upper and lower in her ribs.  She also has some anterior chest pain feels short of breath hurts to take a deep breath. No other complaints she says she is had some low-grade temperatures in the low 100 200.2 may be 100.5 periodically and some chills. Patient was in fair amount of discomfort very pleuritic breathing.  Given 50 mcg of fentanyl 4 mg Zofran IV.  She actually doing better.  Reviewing her records her platelets run about 240,000.  This is cut in half.  She did not have a significant headache and not concerned about an venous thrombosis in the brain however I am concerned about a pulmonary embolism. CT scan obtained and reviewed as below negative for PE or acute abnormality.  Repeat troponin negative, doubt ACS. Possible Covid reaction.  No other significant findings on ED work-up today.  Patient given IV Decadron and repeat dose of fentanyl. She is comfortable with plan discharge home with close outpatient follow-up. Presented again to ED 6/20 with 12 hours of progressive now constant severe low back pain radiating diffusely about the low back into both hips down the back of both legs. Told to F/U with PCP. F/U with PCP on 6/21 and 6/23. One possibility is new onset ITP or immune thrombocytopenia. Plan to Prednisone taper over 3 weeks, also H2 blocker prescribed. CBC twice weekly; follow up CMP with next draw . CTA abdomen rule out portal/mesenteric vein thrombosis or consumptive thrombocytopenia. Tramadol prn pain.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Troponin normal
Clinical narrative: Patient presented to ED 6/16 with chest pain.  Patient got her second Covid vaccination a week ago today.  That night she said she had some numbness on her face from mid lip and chin to the left side of her face.  When she went to bed that night she slept when she woke up that numbness was gone and has not had any since.  She is having body aches now she said the next day she had a lot of bilateral hip pain that seemed to improve some but now it is pain mainly in her back both upper and lower in her ribs.  She also has some anterior chest pain feels short of breath hurts to take a deep breath. No other complaints she says she is had some low-grade temperatures in the low 100 200.2 may be 100.5 periodically and some chills. Patient was in fair amount of discomfort very pleuritic breathing.  Given 50 mcg of fentanyl 4 mg Zofran IV.  She actually doing better.  Reviewing her records her platelets run about 240,000.  This is cut in half.  She did not have a significant headache and not concerned about an venous thrombosis in the brain however I am concerned about a pulmonary embolism. CT scan obtained and reviewed as below negative for PE or acute abnormality.  Repeat troponin negative, doubt ACS. Possible Covid reaction.  No other significant findings on ED work-up today.  Patient given IV Decadron and repeat dose of fentanyl. She is comfortable with plan discharge home with close outpatient follow-up. Presented again to ED 6/20 with 12 hours of progressive now constant severe low back pain radiating diffusely about the low back into both hips down the back of both legs. Told to F/U with PCP. F/U with PCP on 6/21 and 6/23. One possibility is new onset ITP or immune thrombocytopenia. Plan to Prednisone taper over 3 weeks, also H2 blocker prescribed. CBC twice weekly; follow up CMP with next draw . CTA abdomen rule out portal/mesenteric vein thrombosis or consumptive thrombocytopenia. Tramadol prn pain.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatine phosphokinase increased, Chest discomfort, Electrocardiogram ST segment elevation, Pericarditis, Pyrexia
Clinical narrative: myopericarditis (fever, chest pain, troponin elevation, CMRI shows subepicardial delayed enhancement)
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin
Clinical narrative: myopericarditis (fever, chest pain, troponin elevation, CMRI shows subepicardial delayed enhancement)
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac imaging procedure abnormal, Myocarditis, Pyrexia, Troponin increased
Clinical narrative: myopericarditis (fever, chest pain, troponin elevation, CMRI shows subepicardial delayed enhancement)
Age: 71.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Unevaluable event
Clinical narrative: Headache on the left side (4/14/2021 -6/17/2021).
Age: 71.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Headache
Clinical narrative: Headache on the left side (4/14/2021 -6/17/2021).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: UNKNOWN
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Computerised tomogram, Electrocardiogram, Seizure
Clinical narrative: One week to the day of the second injection, Pt collapsed and had a seizure while on a scout trip. Was feeling fine one minute and then out the next. Taken to ER.  EKG, Chest X-Rat and CT all came back fine. Was referred back to his doctor.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Hypoaesthesia, Lethargy
Clinical narrative: Patient became lethargic within 5 minutes.  Within 10 minutes she developed tightness in the chest, difficulty breathing, and numbness in both hands.  We administered an Epi-pen and symptoms began to improve in 10-15 seconds.  She then was evaluated by emergency medical personnel and taken to a local hospital for follow up.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Head injury
Clinical narrative: pt said she is uncomfortable seeing the needle and blood, so advised to look the other way while administration.,   She also said she was nervous, and had felt dizzy in the past while getting vaccination but never fainted or loss consciousness.  The vaccine is administered and she is doing fine.   she said she was feeling ok and walked to the chair.    after about  10 minutes I get called that she fell and hit her head on the floor.  I immediately go to her and ask how she was doing.  she wanted cold water, which was provided and she said she was ok .  advised to sit in the chair for 30 minutes and after she said she was feeling ok,   advised to hold husband hand while waking back to the car.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Blood test, Electrocardiogram, Stress echocardiogram normal
Clinical narrative: Within 90 days of receiving vaccine, (April 02,2021) I experienced Atrial Fibrillation.  Heart rate approached 160bpm, and was admitted to the ER.  I did get lucky and cardioverted on my own, but now I'm on new heart medications (metoprolol) and have had to adjust my lifestyle.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Thrombophlebitis superficial
Clinical narrative: Superficial Thrombophlebitis of the lower leg
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: UNKNOWN
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Impaired work ability, Peripheral swelling
Clinical narrative: I have NO INSURANCE and NO MONEY to go a doctor.  VERY SWOLLEN LEGS FOR 14 DAYS,, low to high grade headaches AND STILL ON GOING, I HAVE TO TAKE PAID DRUGS EVERY DAY TO WORK AT ALL.  I HAVE NOT BEEN ABLE TO WORK EVEN HALF TIME IN LAST 2 WEEKS - NO UNEMPLOMENT IS ALLOWED FOR THIS SO I HAVE ALREADY LOST 2 WEEKS of INCOME!!!
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, Exposure during pregnancy, Human chorionic gonadotropin
Clinical narrative: Miscarriage at 6.5 weeks pregnant 6/23/21
Age: 13.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Balance disorder, Chest X-ray normal, Dizziness, Dyspnoea, Electrocardiogram normal
Clinical narrative: Syncopal Episode after shower. Patient developed new onset nausea and dizziness and woke up on the floor. She felt unsteady on her feet for a few hours after the incident. Also experienced shortness of breath about 2.5 hours after the incident.
Age: 13.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Laboratory test normal, Loss of consciousness, Nausea, Syncope
Clinical narrative: Syncopal Episode after shower. Patient developed new onset nausea and dizziness and woke up on the floor. She felt unsteady on her feet for a few hours after the incident. Also experienced shortness of breath about 2.5 hours after the incident.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood test normal, Ear pain, Fatigue, Fluid replacement
Clinical narrative: Next day on Saturday; developed fatigue & extreme tiredness. Slept most of the day. Did eat two meals with a slight headache. Sunday headaches worsened with ear aches, fatigue & slept all day. Gave Patient Tylenol, pushed fluids to tolerance & used cold compress towels on his head for his headaches.  Monday symptoms persisted & taken to his primary MD & was given medication (Tylenol) & was instructed to administer Ibuprofen if symptoms of headache continue. Prior to MD visit he fainted & vomited attempting to use the toilet. Unable to tolerate any light from the house with sensitivity to his vision. Encouraged to hydrate with GatorAid & fluids with meals to tolerance. Was instructed to take patient to Emergency if symptoms persist till Tuesday to obtain IV hydration. Tuesday late afternoon 4:30 pm, took patient to Emergency & was assessed for blood work which was normal & given IV hydration while there. Wednesday- symptoms subsiding with no further headaches & is now able to walk by himself with improving strength. He ate 3 meals today & hydrating most of the day. Sitting up more & trying to improve his strength & endurance. Less sensitive to light.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Haemoglobin normal, Headache, Hypersomnia, Photophobia
Clinical narrative: Next day on Saturday; developed fatigue & extreme tiredness. Slept most of the day. Did eat two meals with a slight headache. Sunday headaches worsened with ear aches, fatigue & slept all day. Gave Patient Tylenol, pushed fluids to tolerance & used cold compress towels on his head for his headaches.  Monday symptoms persisted & taken to his primary MD & was given medication (Tylenol) & was instructed to administer Ibuprofen if symptoms of headache continue. Prior to MD visit he fainted & vomited attempting to use the toilet. Unable to tolerate any light from the house with sensitivity to his vision. Encouraged to hydrate with GatorAid & fluids with meals to tolerance. Was instructed to take patient to Emergency if symptoms persist till Tuesday to obtain IV hydration. Tuesday late afternoon 4:30 pm, took patient to Emergency & was assessed for blood work which was normal & given IV hydration while there. Wednesday- symptoms subsiding with no further headaches & is now able to walk by himself with improving strength. He ate 3 meals today & hydrating most of the day. Sitting up more & trying to improve his strength & endurance. Less sensitive to light.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Syncope, Vomiting
Clinical narrative: Next day on Saturday; developed fatigue & extreme tiredness. Slept most of the day. Did eat two meals with a slight headache. Sunday headaches worsened with ear aches, fatigue & slept all day. Gave Patient Tylenol, pushed fluids to tolerance & used cold compress towels on his head for his headaches.  Monday symptoms persisted & taken to his primary MD & was given medication (Tylenol) & was instructed to administer Ibuprofen if symptoms of headache continue. Prior to MD visit he fainted & vomited attempting to use the toilet. Unable to tolerate any light from the house with sensitivity to his vision. Encouraged to hydrate with GatorAid & fluids with meals to tolerance. Was instructed to take patient to Emergency if symptoms persist till Tuesday to obtain IV hydration. Tuesday late afternoon 4:30 pm, took patient to Emergency & was assessed for blood work which was normal & given IV hydration while there. Wednesday- symptoms subsiding with no further headaches & is now able to walk by himself with improving strength. He ate 3 meals today & hydrating most of the day. Sitting up more & trying to improve his strength & endurance. Less sensitive to light.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Chest pain, Dysphagia, Dyspnoea
Clinical narrative: Within a few minutes of the shot I had difficulty breathing, swallowing, my throat felt like it was closing up, and I had chest pain. I was incredibly shaky and had to be monitored by the paramedics and receive oxygen for almost 1.5 hours.  In the following days I experienced extreme fatigue, muscle soreness, fever, loss of energy, severe headache. It took me about a month to fully recover and feel well again.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Oropharyngeal discomfort, Pyrexia
Clinical narrative: Within a few minutes of the shot I had difficulty breathing, swallowing, my throat felt like it was closing up, and I had chest pain. I was incredibly shaky and had to be monitored by the paramedics and receive oxygen for almost 1.5 hours.  In the following days I experienced extreme fatigue, muscle soreness, fever, loss of energy, severe headache. It took me about a month to fully recover and feel well again.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Within a few minutes of the shot I had difficulty breathing, swallowing, my throat felt like it was closing up, and I had chest pain. I was incredibly shaky and had to be monitored by the paramedics and receive oxygen for almost 1.5 hours.  In the following days I experienced extreme fatigue, muscle soreness, fever, loss of energy, severe headache. It took me about a month to fully recover and feel well again.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: UNKNOWN
Age: 44.0
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (temperature)
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Breast pain, Electrocardiogram, Left atrial enlargement
Clinical narrative: Around  noon Thu., 6/10/21 I felt pain under my left breast bone. I felt this pain at various times through the week. My mate suggested that I mention it during my televisit on Monday 6/15/21. The nurse practitioner called late and seemed rushed so we didn?t get to it. She was putting in a gastroenterologist consult for me, so I felt that if it was still an issue I would tell the doctor. On Fri., 6/18/21, I was Having trouble starting my day, so I called a nurse line and was told to go to urgent care. After an exam and abnormal EKG, I was told to go to the emergency room.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 38.0
Sex: U
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: UNKNOWN
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Dizziness, Dyspnoea, Electrocardiogram, Feeling abnormal
Clinical narrative: Approximately 9 hours after I got the second dose of Moderna, I woke up and didn't feel well. I ended up fainting due to low blood pressure. I was taken to the ER and given an IV. Then a few days later, I felt unsteadiness/lightheadedness for approximately two weeks. Then that subsided and then I was experiencing shortness of breath for one to two weeks. Ever since the second dose of the vaccine, I've felt off.